PT-141 vs Melanotan II: Tanning vs Libido, Side Effects, Evidence, and Which One Fits

Every figure is an all-in monthly price covering the medication, physician review, refill management and shipping. There is no separate membership fee. Current pricing always lives on each product page; the table is a guide to which product fits which goal.

Melanotan II was designed in the 1980s at the University of Arizona by the Hruby and Hadley laboratories, which had already produced Melanotan I, a linear analogue that later became afamelanotide, the active ingredient in an approved implant for a rare light-sensitivity disorder. Melanotan II was the second-generation, cyclic compound. In the 1990s, men in the Melanotan II studies reported spontaneous erections and higher sexual desire. A metabolite of Melanotan II was taken forward by Palatin Technologies as PT-141, bremelanotide, for that sexual-function effect rather than the tanning one; a 2003 review in the Annals of the New York Academy of Sciences summarises that early programme.

Three names that get confused, three different molecules with a shared ancestry:

Tanning vs libido: the real difference

Both molecules touch both receptors, so the question is which effect is the point and which is the cost. With Melanotan II, pigmentation is the point, and erections, nausea and appetite changes come with it. With PT-141, desire is the point, and a small pigmentation risk comes with it, kept low by capping how often it is used. Taking Melanotan II for libido means accepting skin changes you did not want; taking PT-141 for a tan does not work, because its pigmentation activity is a side effect kept low by design.

As of the FDA pages checked in September 2026:

PT-141 is compoundable because bremelanotide is a component of an FDA-approved drug. Compounded PT-141 at Pepti is a 2 mg/mL multi-dose vial or Pen cartridge with physician-set directions, not the fixed 1.75 mg autoinjector. Melanotan II remains legal to prescribe and dispense with a valid prescription while it awaits review. Neither compounded vial is FDA approved; compounded medications never are. Are peptides FDA approved explains the difference.

Both are injected under the skin (subcutaneously) into the abdomen or thigh, rotating sites.

PT-141 is 0.50 mL, which is 50 units on a U-100 insulin syringe, 2 to 4 hours before sexual activity, no more than 4 doses a month, and never more than one dose in 24 hours. A vial holds 10 doses used on occasions, so the beyond-use date on the label governs replacement. It also comes as a pre-filled Pen cartridge.

Melanotan II is 0.25 mL, 25 units, once daily Monday to Friday, as the original human research used. Twenty doses covers about four weeks, which is why refills run every 28 days, one vial at a time. Because the signal is systemic, where you inject does not decide where you tan.

You do not need to calculate anything: your directions are printed on the vial, and your physician sets them after reviewing your intake. Both ship refrigerated with ice packs. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

PT-141. In the phase 3 trials, nausea was reported by 40% of women versus 1.3% on placebo, and 8% left the trial because of it; flushing (20%), injection-site reactions (13%), headache (11%) and vomiting (5%) followed. Nausea improved for most people by the second dose. Each dose causes a transient blood-pressure rise of about 6 mmHg systolic and 3 mmHg diastolic, peaking two to four hours after the dose. Focal hyperpigmentation of the face, gums or breasts was reported in 1% of women dosing up to eight times a month, but in 38% of people dosed daily for eight days, and is not always reversible. It can reduce absorption of oral medicines taken around the same time and should not be used with oral naltrexone.

Melanotan II. The human studies recorded nausea, facial flushing, stretching and yawning, reduced appetite, sleepiness at the top of the dose escalation, and in men spontaneous erections lasting intermittently for one to five hours after a dose. These are dose-related, and prescribers describe them as most pronounced at the start. It darkens existing moles and freckles, and case reports describe new moles and changing moles during use, with a small number of melanoma diagnoses during or after a course. A 2017 review in the International Journal of Dermatology concluded a causal link has not been established but that the reports warrant caution. Case reports of priapism and toxicity involved self-sourced product at doses far above any reviewed direction.

The shared thread. Both act on MC1R, so both can darken skin; with PT-141 the risk is low at capped, as-needed dosing, and with Melanotan II it is the intended effect. Any mole that changes shape, border or texture, or any new pigmented spot, should be looked at promptly.

For both, stop and contact your physician for any reaction that is severe, spreading, or involves chest pain or difficulty breathing. Seek emergency care for an erection lasting more than four hours.

PT-141 has the stronger evidence by a wide margin: two phase 3 randomised trials in premenopausal women with modest but real effects on desire and distress, a year-long extension and a large pooled safety analysis. Its evidence in men is early-phase, and the compounded vial has not been trialled. Melanotan II has a more solid human footing than most compounded peptides, but it is small: one three-person pigmentation pilot and two ten-person erectile-function studies, all from one group. Nothing characterises how dark or how even a tan will be, how long it lasts, or the long-term safety of repeated courses, and its relationship to melanoma risk is unresolved.

Neither can be bought legitimately without a prescription. Sites selling them "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a state-licensed, FDA-registered US pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and dose changes.

Pepti prescribes both in all 50 states and DC. Step-by-step pages: how to get PT-141 prescribed online and how to get Melanotan II prescribed online.